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Abstract
Invasion by the malaria merozoite depends on recognition of specific erythrocyte surface receptors by parasite ligands.
Plasmodium falciparum uses multiple ligands, including at least two gene families, reticulocyte binding protein homologues
(RBLs) and erythrocyte binding proteins/ligands (EBLs). The combination of different RBLs and EBLs expressed in a
merozoite defines the invasion pathway utilized and could also play a role in parasite virulence. The binding regions of EBLs
lie in a conserved cysteine-rich domain while the binding domain of RBL is still not well characterized. Here, we identify the
erythrocyte binding region of the P. falciparum reticulocyte binding protein homologue 1 (PfRH1) and show that antibodies
raised against the functional binding region efficiently inhibit invasion. In addition, we directly demonstrate that changes in
the expression of RBLs can constitute an immune evasion mechanism of the malaria merozoite.
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Introduction
Malaria is caused by parasites of the genus Plasmodium with an
estimated 300–500 million clinical cases and 1–3 million deaths
annually [1,2]. Plasmodium falciparum is the most prevalent and is
responsible for a large proportion of the mortality associated with
this disease. An essential step in the life cycle of malaria parasites is
the invasion of host erythrocytes by merozoites and this is also an
ideal target for a vaccine based intervention strategy. The invasion
process is characterized by a multitude of specific, but relatively
poorly understood, interactions between protein ligands expressed
by the merozoite and receptors at the erythrocyte surface [3–5]. A
better understanding of the molecular basis for these interactions is
crucial for developing effective strategies to reduce morbidity and
mortality due to malaria. Several molecules implicated in the
invasion process have been identified in the apical organelles
(rhoptry, micronemes, and dense granules) of the merozoite. At
least two gene families: the reticulocyte binding protein homo-
logues (RBLs) and the family of erythrocyte binding proteins/
ligands (EBLs), mediate specific interactions with host cell
receptors thereby defining host cell tropism [4].
Members of the RBLs and EBLs are found in all Plasmodium spp.
so far analyzed and play an important role in parasite virulence,
host cell selection and possibly immune evasion [6,7]. The number
of RBLs present in different Plasmodium spp. varies from two
reticulocyte binding proteins (RBP 1&2) identified in P. vivax to 14
copies of the 235 kDa rhoptry protein (PY235) seen in the rodent
malaria parasite P. yoelii [7]. In P. falciparum six RBL members have
been identified, PfRH1 [8], PfRH2a & 2b [9,10], PfRH3, a
possible pseudogene in a number of laboratory isolates [11],
PfRH4 [12] and PfRH5 [3,12]. EBL homologues include the
Duffy Binding Protein (DBP) of Plasmodium vivax and P. knowlesi
[13], the P. falciparum EBA175, BAEBL (EBA140), EBL1, JESEBL
(EBA181) and PEBL [10,14–18]. These proteins, which are
characterized by the presence of the cysteine rich Duffy Binding
Like (DBL) domain [13] interact with a wide range of different
erythrocyte receptors including Glycophorin A, B and C as well as
the Duffy blood group antigen [13,18–22]. However, among the
RBL proteins, the erythrocyte-binding properties were only
demonstrated for PfRH1, PfRH2b and most recently PfRH4,
with the precise binding regions only now being delineated
[8,10,23].
Erythrocyte invasion by P. vivax requires the interaction between
the DBP [13] and the erythrocyte Duffy antigen [24] as well as the
interaction between the RBP1&2 and an unknown receptor at the
reticulocyte surface [25]. The interaction and recognition
properties of both EBLs and RBLs seem to define the host cell
recognition properties of a merozoite. Numerous studies have
indicated that malarial merozoites, especially from P. falciparum,
can invade erythrocytes through several invasion pathways. This
ability is dependent on the repertoire of parasite ligands expressed
by the merozoite and variations of receptors at the erythrocyte
surface. The various alternative invasion pathways are classified
according to the nature of the erythrocyte receptors involved in
invasion, which in turn are operationally defined by the enzymatic
treatment of erythrocytes that disrupt the specific interactions
these ligands make. PfEBA175 is the best characterized receptor
and recognizes sialic acid components on Glycophorin A [26],
while Glycophorin B, C/D act as receptors for EBLs [18,27,28].
Notwithstanding our current limited understanding of the role of
RBLs in merozoite invasion, these proteins play an important part
in determining host receptor utilization [8,29]. PfRH1 binds to a
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ceptor which has been referred to previously as receptor ‘‘Y’’
[8,30] whilst PfRH2b recognizes the neuraminidase and trypsin
resistant but chymotrypsin sensitive receptor ‘‘Z’’ [31]. PfRH4
binds to a so far uncharacterized neuraminidase and chymotrypsin
resistant receptor [32]. Collectively, recognition of a specific
receptor at the erythrocyte surface is a crucial step for at least
some, if not all RBLs, although direct binding to erythrocytes has
been demonstrated only in the case of PvRBP1/2, one member of
PY235 and PfRH1 and PfRH4 [8,10,23,25,33].
How binding of EBLs or RBLs to specific erythrocyte receptors
ultimately leads to merozoite invasion is an important question
that requires the parasite ligand to be dissected into functional
domains. Such an approach has greatly enhanced our under-
standing of EBL, where the cysteine rich DBL domain was shown
to mediate erythrocyte binding [13], while the cytoplasmic domain
is required for efficient invasion [34]. Partly because of much
lower sequence conservation between members of the RH family,
no functional domain such as the erythrocyte-binding region has
been well characterized. Recently, however, a 30 kDa recombi-
nant protein from PfRH4 was found to bind erythrocyte but
antibodies raised against this region fail to block invasion [23].
Here, we provide the identification of the erythrocyte binding
region of the .2700 amino-acid long PfRH1 protein, a member of
the RBL family. The recognition domain encompasses only 334
residues predicted to include a N-terminal binding domain and a
C-terminal coiled coil region, It binds to erythrocytes in a sialic
acid dependent and chymotrypsin/trypsin resistant manner,
providing evidence that the main binding determinant is
composed of sialic acid residues present within erythrocyte cell
surface glycoproteins or glycolipids. Our findings show that only a
small segment of the protein is involved in receptor recognition.
Thus, it is likely that RBLs mediate other-so far uncharacterized-
functions during the invasion process. Epigenetic silencing of P.
falciparum genes partly regulates the expression of invasion-related
ligands and plays an important role in immune response evasion
[35]. An antiserum raised against the minimal binding region of
PfRH1 contains invasion inhibitory antibodies, and only parasites
that utilize a sialic acid-dependent invasion pathway are inhibited
by this antiserum. In addition switching of the invasion pathway
from a sialic acid-dependent to a sialic acid-independent pathway
renders the inhibitory antibodies ineffective with a concomitant
reduction in the amount of PfRH1 expressed. Thus, invasion
pathway switching in P. falciparum can also serve as a mechanism of
immune evasion.
Results
Defining the erythrocyte binding region of PfRH1 Protein
2 kb overlapping fragments of PfRH1 were cloned into the
pRE4 vector (Figure 1A), which has previously been successfully
used for expression of a number of different malaria parasite
proteins at the surface of COS7 cells [13,26]. In this vector, the
secretory signal sequence and transmembrane segment of HSVgD
were used to target different regions of the malarial proteins to the
COS7 cell surface [13,36]. Subsequently, these , 2Kb constructs,
together with signal sequence and transmembrane segment, were
respectively subcloned into the mammalian cell expression vector
pEGFP-N1, to generate GFP fusion proteins [37]. To establish
whether the cloned regions had erythrocyte binding activity,
COS7 cells were transfected with the GFP constructs. Correct
expression of the GFP fusion proteins was monitored by
fluorescent microscopy of the transfected cells. COS7 cells
transfected with constructs that expressed the different regions of
PfRH1 as GFP-fusion proteins, were tested for their ability to bind
to human erythrocytes. For each construct, the transfection
efficiency was determined by the expression of GFP using
fluorescence microscopy (Figure 1B ii and iv). The number of
COS7 cells with erythrocytes rosettes was determined in 30 fields,
at a magnification of 6200, in three separate experiments. As
shown in Figure 1C, region II (amino acids 334–1000) of PfRH1
possesses the strongest binding ability to untreated human
erythrocytes with .70% binding activity. Regions III, IV and
VI show minimal binding (,10%). No binding was observed for
region I, V, VII and VIII of PfRH1. Negative controls with either
untransfected COS7 cells, with human erythrocytes or COS7 cells
expressing PvDBPII with chymotrypsin-treated human erythro-
cytes, gave no rosettes (data not shown). To further examine the
binding specificity of erythrocytes to region II, we tested the
binding ability of all eight constructs described above to
neuraminidase-, chymotrypsin- and trypsin-treated human eryth-
rocytes respectively. Previously, it was shown that PfRH1 protein
interacts with a neuraminidase-sensitive and trypsin-resistant
receptor at the erythrocyte surface [8,30,38] and that the binding
of EBA-175 is dependent on neuraminidase- and trypsin-sensitive
glycophorin A [26]. From three independent experiments, it is
clear that region II binding is dramatically affected when
erythrocytes are pretreated with neuraminidase (Figure 1C) with
binding being reduced approximately 10 fold. Limited or no
impact on binding of erythrocytes to region II is seen when the
erythrocytes are pretreated with chymotrypsin or trypsin
(Figure 1C). Enzyme treatment of erythrocytes had little effect
on the minimal binding seen to any of the other regions
(Figure 1C). To ensure that the enzyme treatment of erythrocytes
was effective, binding of pretreated erythrocytes to COS7 cells
expressing either PvDBPII or EBA-175RII [37,39] was tested.
Binding of erythrocytes to PvDBPII is resistant to neuraminidase
and trypsin treatment, but sensitive to chymotrypsin. EBA-175RII
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Plasmodium falciparum causes the most virulent form of
human malaria. The pathology of the disease is associated
with the invasion, replication and subsequent destruction
of the erythrocyte by the parasite. Invasion of the host
erythrocyte by the invasive form of the parasite, the
merozoite, is a key step involving the interaction of several
parasite ligands with receptors on the host cell surface. A
better understanding of the molecular basis for these
interactions is crucial for developing effective strategies to
reduce morbidity and mortality due to malaria. Members
of the RBLs and EBLs are found in all Plasmodium spp. so
far analyzed and play an important role in parasite
virulence, host cell selection and possibly immune evasion.
How binding of EBLs or RBLs to specific erythrocyte
receptors ultimately leads to merozoite invasion is an
important question that requires the parasite ligand to be
dissected into functional domains. Here, we show that a
relatively small region of the PfRH1 molecule is involved in
receptor recognition. Only parasites that utilize a sialic
acid–dependent invasion pathway are inhibited by antise-
rum raised against the minimal binding region. In addition,
switching of the invasion pathway from a sialic acid–
dependent to a sialic acid–independent pathway renders
the inhibitory antibodies ineffective with a concomitant
reduction in the amount of PfRH1 expressed. This
demonstrates that invasion pathway switching in P.
falciparum can also serve as a mechanism of immune
evasion.
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For both, the observed binding was as expected, indicating that
enzyme treatment was effective (data not shown). Taken together,
these data show that region RII of PfRH1 has the expected
erythrocyte binding specificity previously demonstrated using the
full length protein [8].
To further delineate the binding region, the same approach for
expressing GFP fusion proteins was used to generate deletion
constructs RII-1, RII-2 and RII-3 of region II (Figure 2A) [37].
Figure 1. Erythrocyte-binding assay on transfected COS7 cells expressing different regions of PfRH1 before and after enzymatic
treatment. (A) Chimeric constructs for the expression of different regions of PfRH1 in 3D7. 3D7 clone RH1 DNA sequence (Genbank accession no:
AF533700) with intro spliced out includes signal sequence (SS, black) and Exon2 (grey) encoding a large extracellular domain and excludes
transmembrane domain and cytoplastic tail. The extracellular domain was divided into eight regions (From I to VIII). Each region (black line with
amino acids no.) is approximately 2 kb with 1 kb overlap between 2 consecutive regions except VIII, which is 1.3 kb. (B) Duffy-positive human
erythrocytes bound to the surface of COS7 cells were visualized as rosettes at a magnification of 6200. (i) Two cells formed rosettes with Duffy-
positive human erythrocytes on bright field. (ii) Cell-associated fluorescence as GFP (green) was found on the same field as in panel (i). (iii) Negative
count of rosette on transfected COS7 cells on bright field. (iv) But two transfected cells (green) were shown on the same field as in panel (iii). Bar,
50um. (C) Comparison of Erythrocyte-binding assay with different regions of PfRH1 after enzymatic treatment. Rosettes were scored in 30 fields at
2006magnification. Data are present as percentage of binding activity (%) after the number of observed rosettes was normalized to 5% transfection
efficiency in three independent experiments. The error bar denotes the SE. * p,0.001, indicating that the binding ability of RII is significantly different
from those obtained from other regions. + p,0.001, indicating that after neuraminidase-treatment, the binding of RII was significantly decreased
compared to untreated erythrocytes.
doi:10.1371/journal.ppat.1000104.g001
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GFP protein expression in fluorescence microscopy. Their binding
abilities to human erythrocytes and enzymes-treated human
erythrocytes were tested in erythrocyte-binding assays
(Figure 2B). Binding was observed with the full-length region II,
as well as the deletion constructs RII-1, RII-2 and RII-3 to
untreated human erythrocytes. Upon neuraminidase treatment, all
the binding activities to human erythrocytes were significantly
Figure 2. Erythrocyte-binding assay on transfected COS7 cells expressing region II deletion constructs and purified recombinant
proteins rRII-3 and rtRVIII. (A) Overall architecture of Region II deletion constructs of PfRH1. RII-1 contains region II amino acids from 334 to 833.
RII-2 consists of region II amino acids from 500 to 1000. RII-3 contains region II amino acids from 500 to 833 (light gray). (B) Comparison of
erythrocyte-binding assay with full-length RII and deletion constructs before and after enzymatic treatment. Rosettes were scored in 30 fields at 2006
magnification. Data are present as percentage of binding activity (%) after the number of observed rosettes was normalized for 5% transfection
efficiency in three independent experiments, and the error bar denotes the SE. * p,0.001, indicating that after neuraminidase-treatment, the binding
of RII and RII-3 was significantly decreased compared to untreated erythrocytes. (C) Purified rRII-3 and rtRVIII were shown in coomassie blue staining
(lane 1 and 2) and detected by western blot with arRII-3, artRVIII and pre-immune serum respectively (lane 3 to 5). (D) Purified rRII-3, rtRVIII as well as
rPvDBPII bound to erythrocytes was detected by Western blot with anti-His antibody (top). The experiments were carried out from a single batch of
purified proteins and run on the same blot. Purified (Pu) rRII-3, rtRVIII and rPvDBPII (Lane 1, 6 and 11). Untreated human erythrocytes (Un) (Lane 2, 7
and 12). Neuraminidase-treated human erythrocytes (Nm) (Lane 3 and 8). Trypsin-treated human erythrocytes (Tr) (Lane 4 and 9).Chymotrypsin-
treated human erythrocytes (Ch) (Lane 5, 10 and 13). Enriched culture supernatant from FCR3 and HB3 bound to erythrocytes was also detected by
western blot with arRII-3 (bottom). Culture medium alone (Me) was used as a negative control. The rest of the labels from bottom panel are the same
as metioned above. Purified rPvDBPII and culture supernatant were used as positive control to determine the specific binding of the rRII-3. Molecular
sizes are indicated on the left (in kDa).
doi:10.1371/journal.ppat.1000104.g002
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treatment with chymotrypsin or trypsin had no inhibitory effect on
rosette formation (Figure 2B). For both binding regions of
PvDBPII and EBA-175RII, the observed binding was as expected,
indicating that enzyme treatment was effective (data not shown).
RII-3 showed similar binding to RII, whereas RII-2 and RII-1 had
a reduced binding activity, compared to the full length RII
protein. The reduction in binding of RII-2 and RII-1 compared to
the RII-3 possibly reflects poor folding of the expressed proteins or
slightly lower expression levels. Previous studies showed that a
single amino acid change can indeed have a significant impact on
how the protein is presented at the cell surface [40,41]. The slight
augmentation in binding provoked by chymotrypsin and trypsin
treatment is probably due to an increased accessibility of the
receptor recognized by PfRH1. Overall, our data suggest that RII-
3 contains the minimal binding region of PfRH1.
Bacterially-expressed recombinant RII-3 specifically binds
to erythrocytes
To confirm the finding that RII-3 contains the minimal binding
region of PfRH1, the corresponding sequence was cloned into a
pET24a(+) vector, containing a 6-His tag at its C terminus and
expressed as a soluble protein in E. coli (Figure 2C). As a negative
control, another pET24a(+) construct expressing a protein of
similar size from region VIII (truncated RVIII, encompassing
amino acids 2434 to 2767) was prepared. After metal affinity and
ion exchange chromatography, the recombinant proteins -named
rRII-3 and rtRVIII- were apparent in coomassie-blue staining,
with the expected molecular mass of ,40 kDa (Figure 2C, lane 1
and 2). Antisera against the two recombinant proteins (arRII-3
and artRVIII) were raised in mice and their reactivity with the
recombinant proteins was confirmed by Western Blot (Figure 2C,
lane 3 and 4). These purified recombinant proteins were
subsequently used in erythrocyte binding assays. A recombinant P.
vivax Duffy Binding Protein DBL domain (rPvDBPII) serving as a
positive control [42], binding to untreated or enzyme-treated
erythrocytes was performed as described [8,22,43]. Bound proteins
were run on the same blot and detected by Western blot using an
anti-His antibody. A 40 kDa band was found in rRII-3 binding to
untreated,chymotrypsin-andtrypsin-treatederythrocytes,butnotin
neuraminidase-treated erythrocytes (Figure 2D, top, lane 2 to lane
5). No binding was detected for rtRVIII either in untreated or
enzymes-treated erythrocytes (Figure 2D, top, lane 7 to lane 10).
Binding ofthe rPvDBPIIwas as expected with the proteinbinding to
untreated but not to chymotrypsin-treated erythrocytes (Figure 2D,
top, lane 12 to 13). In order to confirm whether the recombinant
protein bound to erythrocytes in the same way as the native PfRH1
protein, supernatants from a parasite either expressing PfRH1
(FCR3) or not (HB3) were used in erythrocyte binding assays
(Figure 2D, bottom).PfRH1bindserythrocytesvia a neuraminidase-
sensitive and trypsin-, chymotrypsin-resistant receptor [8,30]. Since
identical properties were observed for the PfRH1 molecule detected
in the FCR3 culture supernatant, this confirms that the recombinant
protein rRII-3 displays the same functional properties as the native
PfRH1 protein using the same assays. These results are consistent
with the presence of the minimal erythrocyte binding domain of
PfRH1 within the RII-3 region.
A new erythrocyte binding domain in Plasmodium
The RII-3 protein (334 amino-acids) is predicted to be
predominantly a-helical (Figure 3A). Circular Dichroic (CD)
spectroscopy of the recombinant RII-3 protein was used to assess
whether it is properly folded and its secondary structure content.
The CD spectrum shows minima at 208 and 222 nm and a
positive peak at 190 nm which are characteristic of proteins rich in
a-helices (Figure 3C). Spectrum deconvolution indicates a 30%
content of a-helices which is consistent with secondary structure
prediction programs. Inspection of the RII-3 sequence (Figure 3A)
reveals an uneven distribution of amino-acids with a large excess of
Ile (16.2%), Lys (14.7%), Gln (12.3%) and Leu (10.2%) residues.
The presence of a heptad repeat motif with an Ile side chain at
position ‘‘a’’ could be detected between residues 262 to 289 of RII-
3 and also in other RB proteins (Figure S1). Furthermore, a weak
sequence identity of 27% for 105 aligned amino-acids with the
second Heptad repeat region B ‘‘HRB’’ of the parainfluenza virus
F protein can be detected between amino-acids 201 to 305 of RII-
3 (data not shown). Interestingly the HRB region of the
parainfluenza F protein, participates in the formation of a trimeric
coiled coil of a-helices [44]. As a confirmation, the program
COILS [45] could detect a coiled coil region in the C-terminal
domain of RII-3, centered at residue 275 and also in PvRBP-1,
PfFRH4, PfRH2a and PfRH3 (Figure S2). To confirm that the
RII-3 forms multimers, we performed gel filtration studies using
the purified recombinant protein rRII-3. The elution profile from
the size-exclusion chromatographic column is consistent with the
presence of multimeric as well as monomeric forms of the protein
(Figure S3). Further work is needed to confirm the role of the C-
terminal coiled coil region in the multimerization of RII-3 and its
influence on the binding avidity.
In the absence of a 3D structure, the exact length of the a-
helical coiled coil is difficult to assess but is likely to span between
28 to 49 residues which translates into a helix of a length
comprised between 43 to 75 A ˚. By analogy with the parainfluenza
F protein, it is thus tempting to describe the RII-3 domain as being
composed of an N-terminal ‘‘head domain’’ possibly involved in
binding the sialic acid moiety on the erythrocyte surface and a C-
terminal multimerization domain mediated by the coiled coil C-
terminal region (Figure 3B).
Previous work on the PfRH4 binding region has shown that a
recombinant protein containing the binding region can block
erythrocyte invasion in a dose dependent manner [23]. To explore
whether the rRII-3 recombinant protein had a similar effect we
incubated erythrocytes with increasing concentration of protein
before the addition of parasites. The rRII-3 inhibited the invasion
in a concentration-dependent manner with IC50 of 0.39 mM, in
contrast no inhibition was observed for rtRVIII (Figure S6A).
Antibodies raised against recombinant proteins rRII-3
and rtRVIII specifically recognize full length PfRH1
As earlier studies have given conflicting results about the size of
PFRH1 in parasite supernatant (Compare [8] to [30]), we
proceeded to further confirm the specificity of the antibodies
using culture supernatant obtained from a P. falciparum PfRH1
knock-out parasite line T994DRH1 as well as its parent line T994
[30] using Western blot analysis. Previous work had shown that an
approximately 240 kDa protein is recognized by PfRH1 specific
sera in T994 but is completely absent from the knock-out line [30]
and an identical result is observed with both antibodies arRII-3
and artRVIII raised here (Figure 4A) with an aSERA5 antiserum
serving as a loading control (Figure 4A) [46]. Western blot on
schizont and merozoite pellets from T994 and T994DRH1
parasites using ag12 antiserum as a loading control [47] confirmed
the lack of expression of PfRH1 protein in the knockout parasites
and further confirmed the specificity of the two antibodies (Figure
S4). Unlike in the parasite supernatant where only a 240 kDa
band is detected, arRII-3 and artRVIII detect one additional
smaller band each representing processing or degradation
products of a larger PfRH1 precursor (Figure S4). This is in line
New Red Blood Cell Binding Domain in Malaria
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is lower then the size predicted from the amino acid sequence.
Immunofluorescence Assays (IFAs) using a MAEBL specific
antibody [48] as a marker for the rhoptries showed that in T994
both arRII-3 and artRVIII gave a punctuate pattern which is
clearly localized with MAEBL in the apical end of merozoites
consistent with the expected expression pattern of PfRH1
(Figure 4B). No staining was observed in T994DRH1 parasites
with either arRII-3 or artRVIII (Figure 4B) further confirming the
specificity of the two antibodies.
Expression of PfRH1 is linked with the utilization of a sialic acid
containing erythrocyte receptor by the parasite during invasion. In
line with this invasion of erythrocytes by T994 is inhibited by
neuraminidase treatment of erythrocytes, whilst at the same
concentration, no inhibitory effect is seen on T994DRH1 (Figure
S5). The enhanced ability of T994DRH1 parasites to invade
neuraminidase-treated erythrocytes reflects a shift in these
parasites towards the utilization of non sialic acid containing
receptors compared with the T994 parent. The different sensitivity
of these two parasite clones towards neuraminidase is also reflected
Figure 3. Bioinformatics and biophysical analysis of the minimal binding region RII-3 of PfRH1. (A) Secondary structure prediction of the
putative erythrocyte binding region of PfRH1. The predicted secondary structure is shown above the sequence with a-helices as springs and b-
strands shown as arrows. The region predicted to form a coiled-coil is boxed and includes residues 262 to 289. Dashed lines indicate regions with no
secondary structure prediction. (B) Proposed topology for the RII-3 binding region. HRB indicates the Heptad repeat region which presents weak
sequence identity with the parainfluenza F protein heptad repeat B that forms a coiled coil of three-helices. (C) CD spectrum of purified recombinant
rRII-3. The graphical output was from SELCON3 (Dichroweb server). The mean residue ellipticity is plotted on the Y axis in degrees cm
2 dmol
21.A
positive peak at 190 nm and a negative peak at 208 and 222 nm indicate the presence a-helical structures in the protein.
doi:10.1371/journal.ppat.1000104.g003
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Western analysis of PfRH1 expression on enriched culture supernatant from T994 and T994DRH1 probed with arRII-3, artRVIII and aSERA5 as loading
control. The expected protein of about 240 kDa was only detected by both antisera in T994 parasites. Molecular sizes are indicated on the left (in
kDa). (B) Double-staining IFAs of T994 and T994DRH1 parasites. T994 (panel i, ii and iii) and T994DRH1 (panel iv, v and vi). Smear of late stage
schizonts and free merozoites were reacted with rabbit polyclonal antiserum aMaebl (second column); arRII-3 or artRVIII (third column). Parasite
nuclei are stained with DAPI (blue). For each panel, Alex Flour 488 goat anti-rabbit IgG (H+L) (green) are to rabbit serum, and Alex Flour 594 goat anti-
mouse IgG (H+L) (red) to mouse sera. In the merged images, areas of overlap between the red and the green signals are shown in yellow. The outline
of single merozoite (panel iii and vi) is shown separately. (C) Comparison of merozoite invasion inhibition with arRII-3 and artRVIII, including pre-
immune serum in 1:10 to 1:2560 dilutions in T994 and T994DRH1. The error bar denotes the SE. * p,0.001, indicating that arRII-3 successfully blocked
the invasion in T994 parasites, compared to the invasion in T994DRH1 with different dilutions. + p,0.001, indicating that arRII-3 significantly
inhibited the invasion compared with artRVIII and pre-immune serum.
doi:10.1371/journal.ppat.1000104.g004
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(Figure 4C). Invasion inhibition assays performed on synchronized
cultures showed significant differences in the ability of the arRII-3
and artRVIII antibodies to inhibit invasion. While both the pre-
immune serum as well as artRVIII had no effect on invasion, at
1:10 dilution, the antiserum arRII-3, raised against the minimal
binding region of PfRH1, successfully blocked invasion in T994
parent with 53% inhibition, compared to the positive control
grown in complete RPMI 1640. The inhibition was concentration-
dependent. By contrast, there was very little impact on invasion
seen at the same amount of arRII-3 in T994DRH1 parasites. This
demonstrates that T994 RH1 knock out parasites are no longer
sensitive to the antibodies against the binding region.
The inhibitory effect of the arRII-3 antibody could be reversed
by pre-incubation of the antiserum with the recombinant rRII-3
protein. Addition of as little as 3.12 mm of rRII-3 reduced invasion
inhibition from approximately 55% to 40% while the addition of
25 mm of protein reduced invasion inhibition to around 10%
(Figure S6B). In contrast pre-incubation with rtRVIII had no
effect on invasion with invasion inhibition still being .50% even
after the addition of 25 mm of protein (Figure S6B). The ability of
rRII-3 to reverse the invasion inhibitory effect of the arRII-3
antiserum in a dose dependent fashion further confirms the
specificity of this antibody.
Inhibition of invasion by P. falciparum parasites with
antisera targeting different regions of PfRH1
Previous work demonstrated that different P. falciparum parasite
clones invade either via a sialic acid-dependent or independent
pathway and the redundancy in the RBL family of proteins at the
level of gene number and sequence and the variations in
transcription and protein expression may allow the parasite to use
alternative invasion pathways [49]. PfRH1 plays an important role
in sialic acid-dependent invasion [30]. We therefore investigated
whether the various anti-RH1 sera exhibited different effects on
invasion by different parasites clones (Figure 5A). As seen with the
T994 parasite clone, neither the pre-immune serum nor artRVIII
had a significant effect in an invasion inhibition assays performed on
synchronized cultures of five clones. By contrast arRII-3 showed
dramatic differences in its ability to inhibit invasion. At a 1:10
dilution, arRII-3 blocked invasion in W2mef, FCR3 and Dd2 at
levels of 66%, 70% and 54% respectively and at a 1:640 dilution,
approximately 30% inhibition was observed for all 3 clones,
compared to the positive control. By contrast there was very little
impact on invasion seen at the same amount of arRII-3 in 3D7 and
HB3 clones. The invasion inhibition assay demonstrates that
antiserum raised against the binding domain of PfRH1 (RII-3)
contains more efficient invasion inhibitory antibodies then those
raised against another region of the protein.
To establish whether there was any link between antibody
sensitivity and sialic acid dependent invasion we determined the
sensitivity of the different parasite clones to neuraminidase-treated
erythrocytes. 3D7 and HB3 were able to invade neuraminidase-
treated erythrocytes more efficiently than W2mef, FCR3 and Dd2
(Figure 5B). Neuraminidase inhibited the invasion of W2mef, FCR3
and Dd2 at low concentrations (0.01-1 mU/ml), but had minimal to
no effect on 3D7 and HB3 clones (Figure 5B and data not shown).
Treatment of erythrocytes with 1 mU/ml neuraminidase inhibited
invasion of W2mef, FCR3 and Dd2 at levels ranging from 56% to
97%, whereas the inhibition for 3D7, HB3 was 0 to 24%. The
parasite clone Dd2 exhibits an intermediate sensitivity to neuramin-
idase treatment compared to W2mef and FCR3. This is reflected in
the slightly lower sensitivity to the invasion inhibitory antibodies
(Figure 5B). To determine whether the differential sensitivity to
arRII-3 antibodies reflected variations in PfRH1 expression in the
different P. falciparum clones, we performed quantitative Western
blots on both culture supernatants and merozoite extracts using
arRII-3 and artRVIII (Figure 5B insert and Figure S7). A protein
band of about 240 kDa was readily detected with both antibodies in
supernatant from W2mef, Dd2 and FCR3, but not from 3D7 and
HB3, when compared with the control protein SERA5 (Figure 5B
insert). Dd2 seems to express an intermediate RH1 level as
compared to W2mef and FCR3. To confirm this observation, a
Western blot of merozoite extract from the same clones was also
probed with arRII-3andartRVIII (FigureS7).Identicalresultswere
obtained usingmerozoitesfromW2mef,Dd2andFCR3,exceptthat
a very small amount of protein could be detected in 3D7 (Figure S7).
Taken together, our data show that parasites that use a sialic acid-
dependent invasion pathway are sensitive to antibodies targeting the
PfRH1 binding domain.
Changes in PfRH1 in W2mef and W2mef (switched)
parasites
The parasite clone W2mef has the capacity to switch from sialic
acid-dependent to –independent invasion by selection on neur-
aminidase-treated erythrocytes [29,50,51]. For instance, W2mef
D175 parasites can switch from sialic acid-dependent to –
independent invasion [29,51]. To obtain W2mef (switched)
parasites able to invade erythrocytes via a sialic acid independent
pathway we cultured W2mef parasites in the neuraminidase-
treated erythrocytes as previously described [32]. The ability of the
arRII-3 and artRVIII antibodies to inhibit invasion of W2mef and
W2mef (switched) parasites was determined (Figure 6A). Unlike
W2mef where invasion was inhibited 71% at a 1:10 dilution and
around 30% at a 1:640 dilution of arRII-3 no effect was found in
W2mef (switched). As expected, the W2mef (switched) but not
W2mef parasites were able to invade neuraminidase-treated
erythrocytes efficiently (Figure S8). These data confirm that the
parasites utilizing a sialic acid-dependent invasion pathway are
sensitive to the antibody targeting the PfRH1 binding domain.
As PfRH1 expression levels are low in parasites less sensitive to
the arRII-3 sera, we investigated its expression level using Western
Blot analysis of equivalent amounts of culture supernatants from
either parasite population. arRII-3 recognizes the appropriate size
(240 kDa) protein in both parasites (Figure 6B). The level of
PfRH1 expression is significantly reduced in switched W2mef as
compared to W2mef. Likewise, a lower amount of expressed
PfRH1 proteins is seen in schizont and merozoite extracts of
switched W2mef parasites (Figure S9). PfRH4 is up-regulated
when parasites switch to a sialic acid-independent invasion
pathway [32,52] while no apparent change in the transcript levels
of PfRH1 was observed. To confirm that this was also the case in
our parasite samples, we performed microarray analysis of RNA
extracted from synchronized schizonts. As previously reported,
both PfRH4 and EBA165 are significantly up-regulated in the
W2mef (switched) parasites but no change was found in the levels
of PfRH1 transcription (Figure 6C). This was confirmed using
quantitative real-time polymerase chain reaction (RT-PCR)
(Figure 6D). To investigate whether other parasites showed a
similar independence of PfRH1 transcription and expression,
quantitative RT-PCR was performed on all the other parasite
clones used in this study (Figure 6D). Parasite clones T994, Dd2
and FCR3 have relatively high PfRH1 levels of transcription, 3D7
has an intermediate transcriptional level and W2mef, W2mef
(switched) and HB3 have low transcriptional levels. The maximum
difference between the lowest and highest transcription levels of
PfRH1 is approximately 7-fold (compare Figure 6D, T994 vs
HB3). These data indicate an absence of correlation between RH1
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tional level of RH1, but has no expression of RH1. W2mef has low
transcriptional level of RH1, but has high expression level of RH1.
Discussion
The invasion of erythrocytes by Plasmodium merozoites is a
multi-step process that involves a sequence of molecular
interactions. The early steps of erythrocyte invasion include: (a)
initial attachment, (b) apical reorientation, and (c) junction
formation that initiate entry into the vacuole [53]. Once the
merozoite–erythrocyte junction is initiated, the next phase begins
with the movement of the junction around the penetrating
merozoite. This involves a number of molecular events that allow
the merozoite to gain physical entry into the erythrocyte within the
parasitophorous vacuole. Parasite ligands encoded by the EBL and
RBL gene family mediate interactions that lead to host cell
recognition and junction formation. Based on work done in P. vivax
RBP-1/2, the RBLs have been implicated in the initial recognition
of the appropriate host-cell, while DBP has been proposed to be
important in the final high affinity binding and tight junction
formation. Recent work in P. knowlesi has experimentally
confirmed the role of the PkDBP in junction formation [54]. At
least one member of both RBLs and EBLs is found in all
Plasmodium spp. analyzed to date, consistent with conserved but
distinct functions of both protein families in merozoite invasion.
Figure 5. Merozoite invasion properties of P. falciparum W2mef, FCR3, Dd2, 3D7 and HB3 clones. (A) Comparison of merozoite invasion
inhibition with arRII-3 and artRVIII, including pre-immune serum in 1:10 and 1:640 dilutions. Positive control was the invasion of merozoites into the
normal complete medium. The error bar denotes the SE. * p,0.001, indicating that the invasion of W2mef, FCR3 and Dd2 were successfully inhibited by
arRII-3, compared to 3D7 and HB3. + p,0.05 indicating that Dd2 exhibit an intermediate sensitivity to inhibitory antiserum as compared to W2mef and
FCR3.(B) Parasiteswerealsoassayedfortheirability toinvadeneuraminidase-treatederythrocytes(1mU/mlfinal).Foreachparasiteclone,thepercentage
ofinhibitionoftheabilitytoinvadeneuraminidase-treatederythrocytes (verticalaxis)isplottedagainstthepercentageofinvasioninhibitionofarRII-3in a
1:10dilution(horizonalaxis).Westernblotofenrichedculturesupernatantfromall5clonesusedinthisstudyandprobedwitharRII-3,artRVIIIandaSERA5
was shown in the insert of (B). No RH1 protein was detected in 3D7 and HB3 clones compared with W2mef, Dd2 and FCR3.
doi:10.1371/journal.ppat.1000104.g005
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PLoS Pathogens | www.plospathogens.org 9 July 2008 | Volume 4 | Issue 7 | e1000104Figure6. Comparison ofPfRH1 expression in merozoite ofW2mef and W2mef (switched). (A) Invasion inhibitionassay ofW2mef and W2mef
(switched) witharRII-3andartRVIII, includingpre-immune serum in 1:10to1:2560dilutions. TheinvasionofW2mefmerozoites was dramaticallyinhibited
byarRII-3. Theerror bardenotes the SE. * p,0.001,indicatingthat theinvasionofW2mef parasitewasdramatically inhibited bythearRII-3underdifferent
dilutions, compared with W2mef (switched) parasites. (B) Enriched culture supernatant from W2mef and W2mef (switched) parasite were probed with
arRII-3 and aSERA5. There was higher decreased in RH1 expression level in W2mef (switched) parasites. Molecular sizes are indicated on the left (in kDa).
(C) Microarray comparison of gene expression intensity between RNA extracted from synchronized late stage parasites (late trophozoites to schizonts
stages) of W2mef and W2mef (switched) parasite. Upregulation of RH4 and EBA165 are shown as red spots. RH1, shown as green spot, in the W2mef
(switched) is similar to the transcription in W2mef. The scatter plot represents log2 expression ratios between the swiched parasite line (positive values)
and its parental line (negative values) (y axis) for all oligonucleotide elements (random order along6axis) for which the hybridization intensity signal
passed the filtering criteria (see material and methods) (D) Real-time PCR. Gene expression in parasite lines used in this study is expressed as comparing
the Ct (cycle threshold) value for each gene of interest (PfRH1) with that of the housekeeping gene (Actin1) based on the specific standard curve. The
results are from three independent experiments, and the error bar denotes the SE.
doi:10.1371/journal.ppat.1000104.g006
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the identification of the relatively conserved DBL domain
responsible for receptor binding of the EBL superfamily to the
erythrocyte. This has enhanced our understanding of the
functional role played by this protein during the invasion process.
Furthermore, the identification of the DBL domain enabled
studies of its role in immune evasion and highlighted the possibility
of using this region for the development of a vaccine that would
block invasion.
Unfortunately, to date, the high sequence diversity of the RBL
superfamily has made it difficult to predict functional regions
within these very large proteins. Considering that RBLs range in
size from around 200 kDa to more than 350 kDa, the study of the
various functions that the RBLs play during merozoite invasion
has been significantly hampered. To address this issue, we used
several approaches to identify the erythrocyte binding region of
one member, PfRH1. Expression of different regions of PfRH1 in
both COS7 cells assays as well as recombinant proteins in E. coli
allowed us to identify an approximately 300 amino-acids
erythrocyte-binding domain that retains the binding properties
reported for the full length PfRH1 protein [8]. Having defined the
binding region of PfRH1 now opens up the prospect of further
structural studies to map the binding determinants on the RII-3
protein structure and its interactions with sialic acid residues on
the erythrocyte receptor. The PfRH1 binding region and also
other members of the PfRBLs family (see Figure S1) contain a
coiled coil motif at their C-terminal end possibly involved in
protein multimerization and the presence of a trimeric complex in
the recombinant protein is consistent with such a prediction. We
propose that the N-terminal end of RII-3 forms a ‘‘head’’ domain
responsible for binding sialic acid residues at the surface of
glycoproteins or glycolipids anchored at the erythrocyte surface.
Support for this role played by the N-terminal region comes from
the recent identification of a PfRH4 binding region which overlaps
by about 89 amino acids with the ‘‘head’’ domain of the PfRH1
binding region [23]. It is now possible to perform detailed studies
on the receptor ligand interactions for at least one member of the
RBL family, enabling us to address this hypothesis. It is apparent
from our study that the region directly involved in erythrocyte
receptor binding constitutes only a relatively small region of the
full-length protein, like in the case of the EBL protein. Further
studies should address the role played by the remainder of the
PfRH1 protein. Receptor binding ultimately leads to signaling
events that allow invasion and junction formation. Defining the
binding region of one member of RBL is an essential first step in
understanding this cascade of events.
Work on EBLs has shown that antibodies against the DBL
domain are potent inhibitors of invasion. These studies have
encouraged significant efforts in developing the DBL domain of
PfEBA-175 and PvDBP as part of a malaria vaccine formulation.
While previous studies have shown that antibodies against different
regions of PfRH1 and PfRH2b [8,31] can inhibitmerozoite invasion
of trypsin treated erythrocytes, our work demonstrates for the first
time that antibodies against the functionally active PfRH1 binding
region contain antibodies that are able to efficiently inhibit invasion
of untreated erythrocytes. Considering that both RBL and EBL
function sequentially during merozoite invasion, a vaccine targeting
both ligands could be more efficient.
The invasion pathways used by P. falciparum vary both in
laboratory isolates as well as in field isolates [38,55,56]. Different
parasites display a relatively stable expression profile of RBLs and
EBLs that correlates with the invasion pathway used [57]. Here we
show that invasion by parasite clones known to use sialic acid-
independent receptors is not affected by antibodies raised against
the PfRH1 binding region as opposed to parasites using sialic acid
dependent receptors. This is consistent with previous observations
that parasites using sialic acid-independent invasion often express
low levels of PfRH1 or -as in the case of 3D7- a nonfunctional
protein [8,30]. High levels of PfRH1 expression correlates strongly
with sialic acid-dependent invasion [30]. Importantly, our findings
indicate that the use of alternative invasion pathways is indeed
associated with immune evasion as it renders invasion inhibitory
antibodies raised against a specific member of RBLs ineffective.
Previous studies of the W2mef parasite clone demonstrated that
a switch from sialic acid -dependent to independent invasion is
associated with the up-regulation of PfRH4 expression, whilst no
changes in PfRH1 transcription was observed [32]. Our micro-
array and quantitative RT-PCR data are consistent with this
observation. Using anti-RH1 antibodies raised against the binding
domain, we found that W2mef merozoite invasion is inhibited
whereas very little impact on invasion using the W2mef (switched)
parasite is seen. Genetic disruption of RBL and EBL molecules
leads to an altered invasion pathway by merozoites [32] and has a
direct impact on the ability of antibodies to inhibit merozoite
invasion [31,57]. This indicated that invasion pathway switching
by the malaria merozoite could provoke immune evasion,
although a direct demonstration using non-genetically manipulat-
ed parasites was hitherto lacking. Our findings demonstrate for the
first time that switching of the invasion pathway by P. falciparum
clones can constitute an effective mechanism for immune evasion.
Previous studies have proposed a ‘‘limited space hypothesis’’ in
which the spatial arrangement of parasite ligands at the apical end
of the merozoite defines whether a ligand is actively involved in
invasion or not [30,31]. This model as well as the transcriptional
data obtained by Stubbs [32] suggest that invasion pathway
switching by W2mef from sialic acid-dependent to independent in
addition to up-regulation of PfRH4 also leads to reorganization of
PfRH1 at the apical end, to a position that makes it inaccessible to
blocking antibodies. Our data on the other hand, suggest that
switching by W2mef involves a reduction of the overall expression
levels of PfRH1, reducing the contribution this protein has on
defining the invasion pathway and thereby also reducing the
effectiveness of the inhibitory antibody. The fact that there is still
some PfRH1 detected by Western blot in merozoites indicates that
expression is not completely eliminated. Therefore, the possibility
exists that these two mechanisms may well work in tandem.
Up-regulation of PfRH4 is also observed in W2mef in the case
of genetic disruption of EBA175 [32], suggesting some functional
redundancy between RBLs and EBLs. Our results on the other
hand, would indicate that up-regulation of PfRH4 is a direct
consequence from the parasite switch to a sialic acid-independent
invasion pathway. Whether changes in the expression of different
EBLs -as seen here for PfRH1- plays a role in the case of the
EBA175 knockout requires further investigations. Further work is
also needed to address the influence between both invasion protein
families in more detail.
To a large extent, transcription and expression levels for RBLs
seem to correlate reasonably well, although this does not seem to
be the case for PfRH1 in W2mef (switched) parasites, where
PfRH1 transcription levels do not change significantly when the
parasite switches invasion pathways [32], despite a significant
reduction in the overall expression of PfRH1 protein. In addition
the quantitative RT-PCR data presented here indicate that while
overall transcriptional levels are somewhat higher in parasite
clones expressing significant amounts of PfRH1, this is not always
the case (See 3D7, W2mef and W2mef (switched)). Epigenetic and
post-transcriptional mechanisms play an important role in
expression control in Plasmodium [35]. This seems to be true for
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regulate protein levels and thereby modulate the invasion
properties of merozoites. Thus, a better understanding of how
transcription and translation of invasion molecules are coupled is
essential to reveal the mechanisms that regulate merozoite
invasion pathways and merozoite immune evasion. All clones of
P. falciparum express multiple invasion ligands and there is a
functional hierarchy, in which some ligands are dominant over
others [57]. The identification of the erythrocyte binding domain
of a PfRH is an important step in dissecting the molecular function
of these proteins. We show that the binding domain could serve as
an effective vaccine candidate against parasite expressing this
ligand, although the ability of the parasite to switch invasion
pathways and therefore circumvent the effect of these antibodies
indicates that additional components are required to make such a
vaccine efficient. We further demonstrate that the activation of the
sialic acid-independent invasion pathway in P. falciparum not only
requires differential gene expression involving PfRH4, but also
post-transcriptional regulation of PfRH1. Our data suggest that
the increase in expression of PfRH4 in parasites that have switched
to a sialic acid-independent pathway is to compensate for the loss
of PfRH1. Importantly, variations in the expression of RBLs are a
clear mechanism by which a merozoite can evade host immunity.
Materials and Methods
Constructs for Expression of Different Regions of PfRH1
on Surface of COS7 Cells
PCR products (for primers see Protocol S1, S1.1–S1.3) where
amplified from P. falciparum 3D7 genomic DNA (gDNA) and
cloned into pRE4 and pEGFP-N1 vector [37] so as to express the
recombinant fusion protein to N- terminus of the EGFP as a
transfection marker.
Erythrocyte-Binding Assay on COS7 Cells
This assay was carried out as described earlier [13]. Transfected
COS7 cells with at least half their surface area covered by
erythrocytes were scored as positive for binding [58]. The number
of rosettes was counted in 30 fields at 200X magnification using an
inverted fluorescent microscope [37,59]. In each experiment, two
wells of COS7 cells were transfected for each construct, and the
data shown are from at least 2 separate experiments. The
transfection efficiency (%) was calculated as total no. of fluorescent
COS7 cells6100/total no. of COS7 cells, while binding activity
(%) was calculated as total no. of fluorescent COS7 cells with
rosettes6100/total no. of COS7 cells. The number of rosettes
observed was normalized for transfection efficiency of 5% [43,60].
Binding was scored as negative when no rosettes were seen in the
entire well. Experimental data are presented as the mean6SE.
One way analysis of variance (ANOVA) was used with a post hoc
(Bonferroni) test to determine the difference between regions. The
significance level was set at p,0.05.
Expression and Purification of Recombinant Proteins rRII-
3, rtRVIII and rPvDBPII in E. coli
DNA sequence of RII-3 and tRVIII recombinant constructs
were amplified by PCR using primers as shown in Protocol S1,
S1.4. The PCR products were digested with EcoRI and XhoI and
cloned into expression vector pET24a(+) (Novagen) to generate a
C-terminal His-tag. BL21-CodonPlus-RIL (Stratagene) was used
to express recombinant rRII-3 and rtRVIII. IPTG at a final
concentration of 0.2mM was added to cultures at A600 nm of 0.6 –
0.8. Induced cultures were allowed to grow overnight at 16uC and
then resuspended in chilled lysis buffer (50 mM Tris, pH 8.0,
200 mM NaCl, 0.1% tween-20 with protease inhibitor cocktail,
EDTA-free (Roche) for rRII-3; 50 mM Tris, pH 8.5, 200 mM
NaCl, with protease inhibitor cocktail, EDTA-free for rtRVIII),
and lysed by sonication. The recombinant protein was purified
under native conditions using nickel-nitrilotriacetic acid-agarose
(Ni-NTA) (Qiagen), followed by ion-exchange chromatography
using a MonoS HR 5/5 column (Amersham) for rRII-3 and
MonoQ 5/50 GL column (Amersham) for rtRVIII.
DNA encoding DBPII (amino acids from 194 to 521 of P. vivax
Duffy-binding protein) was amplified by PCR with primers 59-
GCG CGA GCT CTT ATG TCA CAA CTT CCT GAG TAT
TTT T-39 and 59- GTC GCC ATG GGA GAT CAT AAG AAA
ACG ATC TCT AGT-39 using DBPIIpETDEST42 as template.
The PCR product was digested with NcoI and SacI and cloned
into modified expression vector pET9d (personal contributed by
Prof. Gruber’s lab) to generate N-terminal His-tag. The correct
product was then transformed into BL21-Rosetta-gami for
expression of recombinant DBPII (rPvDBPII). rPvDBPII was
induced at same condition mentioned above and purified under
native conditions using Ni-NTA, followed by gel filtration
chromatography using Superdex 75 Column (Amersham) in
PBS, pH7.4, with a 180 mM NaCl.
Analysis of Secondary Structure Content of Recombinant
Proteins rRII-3 by Circular Dichroic (CD) Spectroscopy
The CD spectra were recorded on a Jasco (J-810) spectro-
polarimeter. Spectra of purified rRII-3 in 50 mM HEPES,
pH 7.1, containing 150 mM NaCl, 50 mm L-arginine, were
recorded at concentration of 200 mg/ml by using three accumu-
lations of data at 0.1 nm intervals. Solvent background was
subtracted and the data processed by the interactive Dichroweb
server [61] using the program SELCON3. The mean residue
ellipticity is plotted on the Y axis with units degrees.cm
2 .dmol
21.
The root mean square deviation between observed and deconvo-
luted data is 0.115.
Western Blot of Parasites Extracts and Culture
Supernatants
Tightly synchronized late schizonts (greater than 80% parasitae-
mia), or purified merozoites were collected as described (http://
www.lumc.nl/1040/research/malaria/ malaria.html). The schiz-
onts or merozoite extracts were lysed directly into sample buffer and
frozen and thawed 3 times. The supernatants were used for SDS-
PAGEusing%gels(forPfRH1protein)and12%gel(forprobedwith
ag12). To make culture supernatant, purified schizonts were placed
back into culture containing only one-fourth of original volume of
completemedium.Cellswereharvestedbycentrifugationafter16hrs
and supernatant were stored in aliquots at 280Cu. The culture
supernatantwasseparated on6%SDS-PAGE(forRH1protein)and
10% gel (for SERA5 protein). Following electrophoresis, gels were
transferred onto nitrocellulose membranes (0.2um) (Bio-Rad)).
Specific proteins were detected by using polyclonal antisera against
rRII-3 and rtRVIII, or mouse monoclonal antiserum g12 raised
against a 34 kDa protein (homologue of the HSP90 co-chaperone
p23) [47] for loading control, or mouse pre-immune serum to check
the specificity, followed by horseradish peroxidase-linked secondary
antibodies (Sigma) and enhanced chemiluminescence (Pierce).
IFAs and Microscopy
Synchronized late-stage schizonts were smeared and air-dried
followed by fixation with 2.5% Glutaraldehyde (Sigma) for 30min
at room temperature. Slides were rinsed in PBS and immersed in
blocking buffer (4% bovine serum albumin and 0.5% Triton X-
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incubated with mouse antisera either arRII-3 or artRVIII and co-
incubated with rabbit antiserum to PfMaebl [48] for 30 min in
blocking buffer, followed by three 5-min washes in 0.05%Tween-20
in PBS. Mouse pre-immune serum was also used in this experiment.
They were then incubated with a mixture of Alex Flour 594 goat
anti-mouse IgG (H+L) and Alex Flour 488 goat anti-rabbit IgG
(H+L) secondary antibodies (Molecular Probe) for 30 min. Slides
werewashed in0.05%Tween-20 inPBS for three 5-min, and dipped
in diamidinophenylindole (DAPI, 0.5ug/ml), and washed in
0.05%Tween-20 in PBS for four 1-min. Vectorshield mounting
medium (Vector laboratories) was applied to the slides, and the
coverslips were sealed. The fluorescence images were captured using
a LSM510 Confocal Microscopy (Zeiss).
Invasion Inhibition Assay
Synchronized late stage schizonts were purified [62] and 160ul
of parasites suspension was added in duplicated in a 96 well flat-
bottom microtitre plate containing 40ul of serial dilution from 1:10
to 1:2560 of either arRII-3, artRVIII or pre-immune serum.
1,000 to 2,000 erythrocytes were scored for presence of rings on
Giemsa-stained smears after 24 h for reinvasion. Invasion was
present as (%) parasitaemia. Parasitaemia (%)=total no. of RBCs
infected with rings/total of RBCs6100. Invasion in the presence
of antisera was compared with positive control of invasion of the
same parasite clones into the normal complete RPMI 1640.
Invasion inhibition efficiencies were determined as follows:
Inhibition efficiency (%)=(12Inv(antisera)dilu)/Inv(positive))6100.
Data shown are from two separate experiments. Experimental
data are presented as the mean6SE. One way analysis of variance
(ANOVA) was used with a post hoc (Bonferroni) test to determine
the different effect of the antisera between parasite lines. The
significance level was set at p,0.05.
RNA Purification, Quantitative Real-time PCR and
microarray analysis
Schizont stage parasites were separated and harvested with
Percoll and total RNA was extracted from schizonts using the
Total RNA Mini Kit (Geneaid). For quantitative real time RT-
PCR isolated total RNA was digested with DNase I (Fermentas)
before converting to cDNA using Invitrogen Superscript First
Strand Synthesis System kit (Invitrogen). 1ng of cDNA in 15 ml
reaction volume was amplified using Sybr Green Master mix
(Applied biosystems) with gene of interest, or housekeeping gene,
followed by analyzing on an ABI 7000 thermocycler under the
cyling conditions: 50uC for 2min, 95uC for 10 min, 9uC for 1min,
53uC for 1min, 60uC for 1min, 95uC for 15sec and 60uC for 1min.
Genes were amplified from genomic DNA extracted from 3D7
and cloned into TOPO-TA cloning vector (Invitrogen) to generate
standard curves for quantitative real-time PCR. Water and no-
reverse transcriptase controls were included in each real-time PCR
and each gene was analyzed in triplicate using RNA from two
independent RNA isolations. Transcriptional level was determined
by comparing the Ct (cycle threshold) value for each gene of
interest with that of the housekeeping gene based on the specific
standard curve as previously described [32,63]. The data are from
three independent experiments, and presented as the mean6SE.
Primers used included:
PfRH1: 59 GATAAAGAGCAAGAAAAACAACAAC 39
and 59 CATTACCTCTTCTTG ATTTCTACCA 39
Actin1: 59TGCACCACCAGAGAGAAAAT 39 and 59
ACTTGGTCCTGATTCATCGT 39.
For the transcriptional profiling we utilized a long oligonucle-
otide microarray containing 10166 microarray elements repre-
senting 5363 P. falciparum genes [64]. The microarray hybridiza-
tions were performed using the standard protocol as previously
described [65] with small modifications. Briefly RNA was isolated
from synchronous W2mef and W2mef (switched) late stage
parasites as previously described [32]. For the hybridization
W2mef or W2mef (switched) cDNA were coupled to Cy5
fluorophore and hybridized against the 3D7 reference pool
(coupled to Cy3). The reference pool consists of RNA samples
representing all developmental stages of the parasite. For each
hybridisation, 12 mg of pooled reference RNA or sample RNA was
used for cDNA reaction. Microarray hybridisations were incubat-
ed for 14–16 h using Maui hybridization system (Bio Micro
Systems). Data were acquired and analyzed by GenePix Pro 3
(Axon Instruments). Array data were stored and normalised using
the NOMAD microarray database (http://ucsf-nomad.source-
forge.net/). The final dataset was filtered as follows: total signal
intensity of each spot must be greater than local background plus
one standard deviation of the background (Dataset S1).
Accession Numbers
The PlasmoDB (http://plasmodb.org/PlasmoDB.shtml) acces-
sion numbers for the genes studied in this paper are PfRh1
(PFD0110W).
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